Sinha BK - Search Results

1

A role for the interleukin 1 receptor in the synergistic antitumor effects of human interleukin 1 alpha and etoposide against human melanoma cells.

Usui N, Mimnaugh EG, Sinha BK. Usui N, et al. Among authors: sinha bk. Cancer Res. 1991 Feb 1;51(3):769-74. Cancer Res. 1991. PMID: 1824825

2

Synergistic antiproliferative effects of the combination of interleukin-1 alpha and doxorubicin against human melanoma cells.

Mimnaugh EG, Monti E, Sebers S, Stetler-Stevenson M, Sinha BK. Mimnaugh EG, et al. Among authors: sinha bk. Oncol Res. 1992;4(10):401-12. Oncol Res. 1992. PMID: 1292755

3

Tyrosinase-induced free radical formation from VP-16,213: relationship to cytotoxicity.

Usui N, Sinha BK. Usui N, et al. Among authors: sinha bk. Free Radic Res Commun. 1990;10(4-5):287-93. doi: 10.3109/10715769009149897. Free Radic Res Commun. 1990. PMID: 1963166

4

Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.

Dusre L, Mimnaugh EG, Myers CE, Sinha BK. Dusre L, et al. Among authors: sinha bk. Cancer Res. 1989 Feb 1;49(3):511-5. Cancer Res. 1989. PMID: 2535960

5

Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance.

Sinha BK, Mimnaugh EG, Rajagopalan S, Myers CE. Sinha BK, et al. Cancer Res. 1989 Jul 15;49(14):3844-8. Cancer Res. 1989. PMID: 2544260

6

Synergistic antitumor activity of etoposide and human interleukin-1 alpha against human melanoma cells.

Usui N, Mimnaugh EG, Sinha BK. Usui N, et al. Among authors: sinha bk. J Natl Cancer Inst. 1989 Dec 20;81(24):1904-9. doi: 10.1093/jnci/81.24.1904. J Natl Cancer Inst. 1989. PMID: 2593167

7

Synergistic interactions of etoposide and interleukin-1 alpha are not due to DNA damage in human melanoma cells.

Monti E, Mimnaugh EG, Sinha BK. Monti E, et al. Among authors: sinha bk. Biochim Biophys Acta. 1993 Jan 22;1180(3):231-5. doi: 10.1016/0925-4439(93)90043-z. Biochim Biophys Acta. 1993. PMID: 8422427

8

Synergistic antiproliferative effects of interleukin-1 alpha and doxorubicin against the human ovarian carcinoma cell line (NIH:OVCAR-3).

Monti E, Mimnaugh EG, Sinha BK. Monti E, et al. Among authors: sinha bk. Biochem Pharmacol. 1993 May 25;45(10):2099-107. doi: 10.1016/0006-2952(93)90022-o. Biochem Pharmacol. 1993. PMID: 8512591

9

Doxorubicin-induced cross-resistance to tumor necrosis factor (TNF) related to differential TNF processing.

Fruehauf JP, Mimnaugh EG, Sinha BK. Fruehauf JP, et al. Among authors: sinha bk. J Immunother (1991). 1991 Jun;10(3):165-73. doi: 10.1097/00002371-199106000-00002. J Immunother (1991). 1991. PMID: 1651105

10

Biochemical and pharmacological characterization of MCF-7 drug-sensitive and AdrR multidrug-resistant human breast tumor xenografts in athymic nude mice.

Mimnaugh EG, Fairchild CR, Fruehauf JP, Sinha BK. Mimnaugh EG, et al. Among authors: sinha bk. Biochem Pharmacol. 1991 Jul 5;42(2):391-402. doi: 10.1016/0006-2952(91)90727-m. Biochem Pharmacol. 1991. PMID: 1677569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters